BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lymphoma AND BCL11B, CTIP-2, 64919, ENSG00000127152, CTIP2, hRIT1-alpha, Q9C0K0 AND Treatment
18 results:

  • 1. Myeloid/natural killer (NK) cell precursor acute leukemia as a distinct leukemia type.
    Nishimura A; Yokoyama K; Naruto T; Yamagishi C; Imamura T; Nakazono H; Kimura S; Ito M; Sagisaka M; Tanaka Y; Piao J; Namikawa Y; Yanagimachi M; Isoda T; Kanai A; Matsui H; Isobe T; Sato-Otsubo A; Higuchi N; Takada A; Okuno H; Saito S; Karakawa S; Kobayashi S; Hasegawa D; Fujisaki H; Hasegawa D; Koike K; Koike T; Rai S; Umeda K; Sano H; Sekinaka Y; Ogawa A; Kinoshita A; Shiba N; Miki M; Kimura F; Nakayama H; Nakazawa Y; Taga T; Taki T; Adachi S; Manabe A; Koh K; Ishida Y; Takita J; Ishikawa F; Goto H; Morio T; Mizutani S; Tojo A; Takagi M
    Sci Adv; 2023 Dec; 9(50):eadj4407. PubMed ID: 38091391
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Differential expression of bcl11b and CDKN2A in CD30-positive peripheral T cell lymphoma: Retrospective study.
    Wang Y; Zhang F; Gao N; Bu P; Cui W; Xi Y
    Medicine (Baltimore); 2023 Nov; 102(46):e35531. PubMed ID: 37986346
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. International Consensus Classification of acute lymphoblastic leukemia/lymphoma.
    Duffield AS; Mullighan CG; Borowitz MJ
    Virchows Arch; 2023 Jan; 482(1):11-26. PubMed ID: 36422706
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Decreased TCF1 and bcl11b expression predicts poor prognosis for patients with chronic lymphocytic leukemia.
    Liang T; Wang X; Liu Y; Ai H; Wang Q; Wang X; Wei X; Song Y; Yin Q
    Front Immunol; 2022; 13():985280. PubMed ID: 36211334
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Human Adipose-derived mesenchymal stem cells promote lymphocyte apoptosis and alleviate atherosclerosis via miR-125b-1-3p/bcl11b signal axis.
    Yu C; Tang W; Lu R; Tao Y; Ren T; Gao Y
    Ann Palliat Med; 2021 Feb; 10(2):2123-2133. PubMed ID: 33725769
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Deleterious point mutations in T-cell acute lymphoblastic leukemia: Mechanistic insights into leukemogenesis.
    Roy U; Raghavan SC
    Int J Cancer; 2021 Sep; 149(6):1210-1220. PubMed ID: 33634864
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. bcl11b suppresses tumor progression and stem cell traits in hepatocellular carcinoma by restoring p53 signaling activity.
    Yang WJ; Sun YF; Jin AL; Lv LH; Zhu J; Wang BL; Zhou Y; Zhang CY; Wang H; Hu B; Wang PX; Te L; Pan BS; Zhou J; Fan J; Yang XR; Guo W
    Cell Death Dis; 2020 Oct; 11(10):895. PubMed ID: 33093445
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Increased expression of bcl11b and its recruited chromatin remodeling factors during highly active antiretroviral therapy synergistically represses the transcription of human immunodeficiency virus type 1 and is associated with residual immune activation.
    Wang J; Yang Z; Wu NP; Yang J
    Arch Virol; 2020 Feb; 165(2):321-330. PubMed ID: 31828511
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. bcl11b is frequently downregulated in HTLV-1-infected T-cells through Tax-mediated proteasomal degradation.
    Permatasari HK; Nakahata S; Ichikawa T; Morishita K
    Biochem Biophys Res Commun; 2017 Aug; 490(3):1086-1092. PubMed ID: 28669733
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. bcl11b-Mediated Epigenetic Repression Is a Crucial Target for Histone Deacetylase Inhibitors in Cutaneous T-Cell lymphoma.
    Fu W; Yi S; Qiu L; Sun J; Tu P; Wang Y
    J Invest Dermatol; 2017 Jul; 137(7):1523-1532. PubMed ID: 28288848
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Assessment of Radiation Induced Therapeutic Effect and Cytotoxicity in Cancer Patients Based on Transcriptomic Profiling.
    Karim S; Mirza Z; Chaudhary AG; Abuzenadah AM; Gari M; Al-Qahtani MH
    Int J Mol Sci; 2016 Feb; 17(2):250. PubMed ID: 26907258
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Mutational spectrum of adult T-ALL.
    Neumann M; Vosberg S; Schlee C; Heesch S; Schwartz S; Gökbuget N; Hoelzer D; Graf A; Krebs S; Bartram I; Blum H; Brüggemann M; Hecht J; Bohlander SK; Greif PA; Baldus CD
    Oncotarget; 2015 Feb; 6(5):2754-66. PubMed ID: 25595890
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Aberrant expression of bcl11b in mycosis fungoides and its potential role in interferon-induced apoptosis.
    Gu X; Wang Y; Zhang G; Li W; Tu P
    J Dermatol; 2013 Aug; 40(8):596-605. PubMed ID: 23682716
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. bcl11b suppression does not influence CD34(+) cell differentiation and proliferation.
    Shen Q; Huang X; Chen S; Yang L; Chen S; Li B; Wu X; Grabarczyk P; Przybylski GK; Schmidt CA; Li Y
    Hematology; 2012 Nov; 17(6):329-33. PubMed ID: 23168072
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Comprehensive cytogenetic study of primary cutaneous gamma-delta T-cell lymphoma by means of spectral karyotyping and genome-wide single nucleotide polymorphism array.
    Yamamoto-Sugitani M; Kuroda J; Shimura Y; Nagoshi H; Chinen Y; Ohshiro M; Mizutani S; Kiyota M; Nakayama R; Kobayashi T; Uchiyama H; Matsumoto Y; Horiike S; Taniwaki M
    Cancer Genet; 2012 Sep; 205(9):459-64. PubMed ID: 22819381
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Down regulation of bcl11b expression inhibits proliferation and induces apoptosis in malignant T cells by bcl11b-935-siRNA.
    Huang X; Chen S; Shen Q; Chen S; Yang L; Grabarczyk P; Przybylski GK; Schmidt CA; Li Y
    Hematology; 2011 Jul; 16(4):236-42. PubMed ID: 21756541
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Gene expression profiles in bcl11b-siRNA treated malignant T cells.
    Huang X; Shen Q; Chen S; Chen S; Yang L; Weng J; Du X; Grabarczyk P; Przybylski GK; Schmidt CA; Li Y
    J Hematol Oncol; 2011 May; 4():23. PubMed ID: 21575156
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Activation of TLX3 and NKX2-5 in t(5;14)(q35;q32) T-cell acute lymphoblastic leukemia by remote 3'-bcl11b enhancers and coregulation by PU.1 and HMGA1.
    Nagel S; Scherr M; Kel A; Hornischer K; Crawford GE; Kaufmann M; Meyer C; Drexler HG; MacLeod RA
    Cancer Res; 2007 Feb; 67(4):1461-71. PubMed ID: 17308084
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.